Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: Nov 12, 2024
BERKELEY HEIGHTS, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today announced third quarter financial results and provided a business update.
Read more at globenewswire.com0.34
-0.01 (-1.73%)
CYCLACEL PHARMACEUTICALS - CYCC 6 PERP
NASDAQ:CYCCP (2/21/2025, 8:11:33 PM)
7.39
-0.55 (-6.93%)
Find more stocks in the Stock Screener
CYCC Latest News and Analysis
17 days ago - ChartmillThese stocks are moving in today's after hours sessionAfter the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
